ABSI
Absci Corp
NASDAQ: ABSI · HEALTHCARE · BIOTECHNOLOGY
$4.71
-3.09% today
Updated 2026-04-29
Market cap
$732.16M
P/E ratio
—
P/S ratio
261.48x
EPS (TTM)
$-0.84
Dividend yield
—
52W range
$2 – $5
Volume
4.1M
Absci Corp (ABSI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-6.03M | $-10.97M | $-60.60M | $-81.34M | $-64.64M | $-72.40M | $-92.92M |
| Capital expenditures | $1.10M | $2.18M | $38.05M | $16.18M | $860000.00 | $404000.00 | $1.11M |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $42000.00 | $420000.00 | $10.61M | $12.54M | $11.42M | $19.45M | $18.32M |
| Free cash flow | $-7.13M | $-13.15M | $-98.64M | $-97.51M | $-65.50M | $-72.81M | $-94.03M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $208.22M | — | — | — | — |